conventional

ApprovedSmall molecule

PPopulation Health Research Institute

conventional is one of 160 small molecule programs targeting Arrhythmia. It is currently in Approved.

Indications

Total Trials

Active Trials

159

Competitors

Pipeline

Status by Indication[3][1]

Indication

ArrhythmiaActive, not recruiting

Bacterial VaginosisActive, not recruiting

HyperglycemiaActive, not recruiting

EpilepsyActive, not recruiting

COVID-19Active, not recruiting

ArrhythmiaApproved

Active, not recruiting

Bacterial VaginosisPhase 2/Phase 3

Active, not recruiting

HyperglycemiaPhase 2

Active, not recruiting

EpilepsyApproved

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

conventional

PPopulation Health Research Institute

Approved

1 2

Spikevax

Moderna

Preclinical

21 3

Bnt162b2

BioNTech

Preclinical

29 4

COVID-19 Vaccine

Moderna

Preclinical

27 5

Biaxin

AbbVie

Preclinical

2 6

Aldactone

Pfizer

Preclinical

1 7

Nexavar

Bayer

Preclinical

1 8

Stivarga

Bayer

Preclinical

1 9

Aimovig

Amgen

Preclinical

1 10

Singulair

AstraZeneca

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Epilepsy1 trial

Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes

Unknown status·—·Phase 4·NCT03490487·100 enrolled

Bacterial Vaginosis1 trial

Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis

Completed·—·Phase 2/3·NCT02365389·64 enrolled

Post Operative Pain1 trial

Postoperative Pain Alleviation in Open Heart Surgery

Completed·—·N/A·NCT03106818·90 enrolled

COVID-191 trial

Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore

Completed·KKing Edward Medical University·N/A·NCT04871633·66 enrolled

Pediatric1 trial

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Completed·NNayera Hazaa Elsherif·N/A·NCT03412188·36 enrolled

3 more indications

Hyperglycemia1 trial

Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia

Completed·MMarcus Saemann·Phase 2·NCT00830297·50 enrolled

Arrhythmia1 trial

Prevention of Arrhythmia Device Infection Trial (PADIT)

Completed·PPopulation Health Research Institute·Phase 4·NCT01628666·12,814 enrolled

Unspecified1 trial

Topical Insulin Versus Autologous Serum After Corneal Surgeries

Unknown status·—·Phase 1·NCT05331859·250 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for conventional. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — conventional compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for conventional. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Population Health Research Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: PPopulation Health Research Institute

conventional

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Epilepsy1 trial

Bacterial Vaginosis1 trial

Post Operative Pain1 trial

COVID-191 trial

Pediatric1 trial

Hyperglycemia1 trial

Arrhythmia1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News